How effective is Pravachol for Hyperlipidaemia? (a real world drug study)

Summary:

Overall ratings: 3/5
Long term ratings: 3/5

This is a phase IV clinical study of how effective Pravachol (pravastatin sodium) is for Hyperlipidaemia and for what kind of people. The study is created by eHealthMe from 4 Pravachol users and is updated continuously.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.

What is Hyperlipidaemia?

Hyperlipidaemia (presence of excess lipids in the blood) is found to be associated with 1,425 drugs and 1,408 conditions by eHealthMe. Check the latest studies of Hyperlipidaemia.


On Jul, 31, 2026

4 people are studied for taking Pravachol in Hyperlipidaemia

Overall effectiveness (number of people):

Does Pravachol work for your Hyperlipidaemia (overall)?

Long term (1+ years) effectiveness (number of people):

Does Pravachol work for your Hyperlipidaemia (long term)?

Pravachol effectiveness for Hyperlipidaemia (number of people):

Overall:
  • not at all: 0
  • somewhat: 1
  • moderate: 2
  • high: 1
  • very high: 0
Long Term:
  • not at all: 0
  • somewhat: 0
  • moderate: 1
  • high: 0
  • very high: 0

Gender of people who take Pravachol for Hyperlipidaemia *:

  • female: 25 %
  • male: 75 %

Age of people who take Pravachol for Hyperlipidaemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 75 %
  • 60+: 25 %

Who find Pravachol more effective for Hyperlipidaemia?

Gender of people who take Pravachol for Hyperlipidaemia *:

  • female: 100 %
  • male: 0.0 %

Age of people who take Pravachol for Hyperlipidaemia *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 100 %
  • 60+: 0.0 %

* Approximation only. Some reports may have incomplete information.

Do you take Pravachol?

- You can start a phase IV clinical trial to monitor Pravachol safety and effectiveness.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Alternative drugs to, pros and cons of:

Treatments, associated drugs and conditions:

How the study uses the data?

The study is based on pravastatin sodium (the active ingredients of Pravachol) and Pravachol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: